SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The stock is trending due to heightened speculation around impending Phase 3 results for its lead AML immunotherapy, GPS, with the CEO's recent remarks on "curative outcomes" fueling strong community belief in a positive data readout and potential buyout. This has intensified discussions of a significant short squeeze as institutional accumulation is noted and the stock approaches new highs.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending amid intense community speculation of an impending short squeeze, driven by perceived technical breakouts and widespread anticipation of strategic announcements or positive earnings from Chairman Ryan Cohen, with many noting its resilience in a volatile market.

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.

AN2 Therapeutics Inc

ANTX is trending due to a cluster of recent positive developments including a $40 million private placement, new strategic partnerships with GSK and DNDi, and an analyst upgrade, sparking intense community debate between aggressive bulls targeting significant price appreciation and bears pointing to past trial setbacks and potential dilution.

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.

Relmada Therapeutics Inc

Relmada Therapeutics is trending following positive 12-month Phase 2 trial data for its bladder cancer candidate, NDV-01, which reported a durable 76% complete response rate and reinforced plans for Phase 3 trials. The company's recently announced $160 million private placement to fund further development is also a key talking point, with the community actively discussing the drug's potential and the financing's implications for its future trajectory.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is trending as escalating Middle East tensions, particularly the Strait of Hormuz closure and production cuts by key oil producers, have sent crude prices soaring. Community discussion is highly polarized, with some anticipating further parabolic gains, while others foresee a sharp pullback as G7 nations consider a significant strategic oil reserve release and potential escort missions to reopen the strait.

Aureus Greenway Holdings, Inc. engages in the ownership and operation of public golf country clubs, namely Kissimmee Bay Country Club and Remington Golf Club. It operates through the following segments: Golf Recreation, Retail Golf Products, and Equipment and Facilities Rental, Membership Dues, Food and Beverage Services, and Ancillary Services and Amenities. The Golf Recreation, Retail Golf Products, and Equipment and Facilities Rental segment is involved in the collection of fees for every round of eighteen holes, provision of driving ranges for practice, sale of golf apparel and equipment, and rental of golf products and cars. The Membership Dues segment refers to the membership fees for customers to access the club's facilities and services for a set period or daily at the point of sale. The Food and Beverage Services segment provides culinary services such as catering. The Ancillary Services and Amenities segment offers leisure activities hosted in an on-premises clubhouse, kitchen, bar, and dining area. The company was founded on December 22, 2023 and is headquartered in Kissimmee, FL.

Aureus Greenway Holdings Inc.

Aureus Greenway Holdings is trending due to its announced merger with drone manufacturer Powerus, backed by Eric and Donald Trump Jr., signaling a significant pivot into the defense-drone sector amid rising military tech demand. Community discussion reflects strong enthusiasm for potential government contracts and short squeeze opportunities, while also acknowledging concerns around the stated merger valuation and recent share dilution.

ProShares Trust - ProShares UltraShort Bloomberg Crude Oil -2x Shares

ProShares UltraShort Bloomberg Crude Oil

ProShares UltraShort Bloomberg Crude Oil ($SCO) is highly active as crude oil experiences significant volatility, with many traders anticipating a sharp downturn after recent geopolitical tensions led to price surges. The community is aggressively buying this inverse ETF, viewing current oil levels as overbought and primed for a major correction.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is trending as escalating Middle East tensions and surging oil prices fuel expectations for increased market volatility, with the community sharply divided between those buying dips as a market hedge and others anticipating a "VIX crush" or inherent decay in the leveraged ETF.

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

CAMP4 Therapeutics Corp.

Calamp Corp.

Calamp Corp. is currently trending due to its Chapter 11 bankruptcy filing and plan to go private, which is expected to eliminate existing shareholder equity. Investors are actively discussing the impending delisting and the ultimate value of their holdings.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. is trending after resolving its legal dispute with Novo Nordisk and announcing a partnership to offer FDA-approved GLP-1 weight-loss medications on its platform. This development has largely eliminated the previous bear thesis, fueling significant short-squeeze speculation and community discussion about the company's long-term potential as a digital health and wellness platform.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

VALE S.A. (VALE) is a Top Dividend Stock Right Now: Should You Buy?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does VALE (VALE) have what it takes? Let's find out.

China's Rare Earth Dominance and the Strategic Failure of the West

China's Rare Earth Dominance and the Strategic Failure of the West China's Rare Earth Dominance and the Strategic Failure of the West PR Newswire NEW YORK, March 3, 2026 OilPrice.com Market...

VALE S.A. (VALE) Stock Drops Despite Market Gains: Important Facts to Note

In the latest trading session, VALE S.A. (VALE) closed at $16.99, marking a -1.11% move from the previous day.

Barclays Forecasts Strong Price Appreciation for Vale (NYSE:VALE) Stock

Barclays boosted their target price on Vale from $15.50 to $16.50 and gave the stock an "overweight" rating in a report on Monday...

Here's Why VALE S.A. (VALE) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Vale vs. Cleveland-Cliffs: Which Stock is a Better Buy Now?

VALE's strong output, cost cuts and rising earnings estimates stand out against CLF's losses and auto exposure. Which is the better bet?

VALE S.A. (VALE) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching VALE (VALE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

VALE S.A. (VALE) is a Top-Ranked Growth Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Verus Capital Partners LLC Raises Holdings in Vale S.A. $VALE

Verus Capital Partners LLC increased its position in shares of Vale S.A. (NYSE:VALE - Free Report) by 117.0% during the 3rd quarter, according to the company in its most recent disclosure with the...

Vale S.A. $VALE Shares Sold by Journey Advisory Group LLC

Journey Advisory Group LLC cut its stake in Vale S.A. (NYSE:VALE - Free Report) by 27.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Vale SA engages in the production and exportation of iron ore, pellets, manganese, and iron alloys. It operates through the following segments: Iron Solutions, Energy Transition Materials and Others. The Iron Solutions segment includes the production and extraction of iron ore, iron ore pellets, manganese, other ferrous products, and logistic services. The Energy Transition Materials segment involves the production and extraction of nickel and its by-products. Others includes the revenues and cost of other products, services, research and development, investments in joint ventures and associates of other business. The company was founded on June 1, 1942 and is headquartered in Rio de Janeiro, Brazil.

Current Price	$14.97
Prev Close	$14.97
Open	$14.78
Dividend Yield	8.46%
50-Day Moving Average	$15.51
Beta	0.83
Avg. Volume	38.37M
PE Ratio	27.68

52-Week High	$17.72
52-Week Low	$7.47
Market Capitalization	$63.9B
EPS (Annual)	$0.5792
Price to Book	1.90
Revenue Per Employee	$580,996.63

VALE
Vale S.A.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VALE News

VALEVale S.A.